For instance, MCC950 was able to rescue neonatal lethality in a genetic mouse model of Cryopyrin-Associated Autoinflammatory Syndromes (CAPS) caused by NLRP3 activating mutation while targeted blockade of IL−1β alone was unable to do so (8, 43). Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.